Relative Strength Chart Protagonist Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-10 EDT			After hours 19:56:20
131.42 ^USD	-4.52%		137.72	+4.79%

07-07	Truist Raises Price Target on Protagonist Therapeutics to $145 From $121, Keeps Buy Rating	MT
06-25	Protagonist Therapeutics Insider Sold Shares Worth $1,061,460, According to a Recent SEC Filing	MT

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PROTAGONIST THERAPEUTICS, INC.	Other Biotechnology & Medical Research	-4.52%	-0.15%	+50.47%	+148.78%	+184.52%	8.45B